{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:08:51Z","timestamp":1648613331102},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1995,6,1]],"date-time":"1995-06-01T00:00:00Z","timestamp":801964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol. Infect. Dis."],"published-print":{"date-parts":[[1995,6]]},"DOI":"10.1007\/bf02113429","type":"journal-article","created":{"date-parts":[[2005,9,13]],"date-time":"2005-09-13T21:54:43Z","timestamp":1126648483000},"page":"512-519","source":"Crossref","is-referenced-by-count":5,"title":["Emergence and clinical relevance of mutations associated with zidovudine resistance in asymptomatic HIV-1 infected patients"],"prefix":"10.1007","volume":"14","author":[{"given":"E. J.","family":"Calder\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. J.","family":"Medrano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Luque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Larder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"S\u00e1nchez-Quijano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02113429_CR1","first-page":"373","volume-title":"AIDS. Etiology, diagnosis, treatment, and prevention","author":"DD Richman","year":"1992","unstructured":"Richman DD: Azidothymidine and other deoxynucleoside analogues. In: DeVita VT, Hellman S, Rosenberg SA (ed): AIDS. Etiology, diagnosis, treatment, and prevention. J.B. Lippincott Company, Philadelphia, 1992, p. 373\u2013395."},{"key":"BF02113429_CR2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM198707233170401","volume":"317","author":"MA Fischl","year":"1987","unstructured":"Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volverding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Schooley RT, Jackson GG, Durack DT, Phil D, King D, the AZT Collaborative Working Group: The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. New England Journal of Medicine 1987, 317: 185\u2013191.","journal-title":"New England Journal of Medicine"},{"key":"BF02113429_CR3","doi-asserted-by":"crossref","first-page":"727","DOI":"10.7326\/0003-4819-112-10-727","volume":"112","author":"MA Fischl","year":"1990","unstructured":"Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy D, Dolin R, Powderly WG, Allan JD, Wong B, Merigan TC, McAuliffe VJ, Hyslop NE, Rhame FS, Balfour HH, Spector SA, Volverding P, Petinelli C, Anderson J, the AIDS Clinical Trial Group: The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection: a double-blind, placebo-controlled trial. Annals of Internal Medicine 1990, 112: 727\u2013737.","journal-title":"Annals of Internal Medicine"},{"key":"BF02113429_CR4","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJM199004053221401","volume":"322","author":"PA Volberding","year":"1990","unstructured":"Volberding PA, Lagakos SW, Koch MA, Vettinelli C, Myers MW, Booth DK, Balfour HH, Richman RC, Bartlett JA, Hirsch MS, Murphy RL, Hardy WD, Soeyro R, Fischl MA, Bartlett JG, Merigan TC, Hyslop NE, Richman DD, Valentine ST, Corey L, the AIDS Clinical Trials Group of the National Institute of Health, Allergy and Infectious Diseases: Zidovudine in asymptomatic human immunodeficiency virus infection: a controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. New England Journal of Medicine 1990, 322: 941\u2013949.","journal-title":"New England Journal of Medicine"},{"key":"BF02113429_CR5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1056\/NEJM199307293290501","volume":"329","author":"DA Cooper","year":"1993","unstructured":"Cooper DA, Gatell JM, Kroon S, Clumeck N, Millard J, Goebel FD, Bruun JN, Stingl G, Melville RL, Gonz\u00e1lez-Lahoz J, Stevens JW, Fiddian AP, the European-Australian Collaborative Group: Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. New England Journal of Medicine 1993, 329: 297\u2013303.","journal-title":"New England Journal of Medicine"},{"key":"BF02113429_CR6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(94)90006-X","volume":"343","author":"Concorde Coordinating Committee","year":"1994","unstructured":"Concorde Coordinating Committee: Concorde: MRC\/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection. Lancet 1994, 343: 871\u2013881.","journal-title":"Lancet"},{"key":"BF02113429_CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0140-6736(92)90140-X","volume":"339","author":"G Tudor-Williams","year":"1992","unstructured":"Tudor-Williams G, St. Clair MH, McKinney RE, Maha M, Walter E, Santacroce S, Mintz M, O'Donnell K, Rudoll T, Vavro CL, Connor EM, Wilfert CM: HIV-1 sensitivity to zidovudine and clinical outcome in children. Lancet 1992, 339: 15\u201319.","journal-title":"Lancet"},{"key":"BF02113429_CR8","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1126\/science.2467383","volume":"243","author":"BA Larder","year":"1989","unstructured":"Larder BA, Darby G, Richman DD: HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 1989, 243: 1731\u20131734.","journal-title":"Science"},{"key":"BF02113429_CR9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0140-6736(90)93391-2","volume":"336","author":"CAB Boucher","year":"1990","unstructured":"Boucher CAB, Tersmette M, Lange JMA, Kellam P, De Goede REY, Mulder JW, Darby G, Goudsmit J, Larder B: Zidovudine sensitivity of human immunodeficiency viruses from high-risk, symptom-free individuals during therapy. Lancet 1990, 336: 585\u2013590.","journal-title":"Lancet"},{"key":"BF02113429_CR10","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1126\/science.2479983","volume":"246","author":"BA Larder","year":"1989","unstructured":"Larder BA, Kemp SD: Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 1989, 246: 1155\u20131158.","journal-title":"Science"},{"key":"BF02113429_CR11","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/infdis\/164.6.1075","volume":"164","author":"DD Richman","year":"1991","unstructured":"Richman DD, Guatelli JC, Grimes J, Tsiatis A, Gingeras T: Detection of mutations associated with zidovudine resistance in human immunodeficiency virus by use of the polymerase chain reaction. Journal of Infectious Diseases 1991, 164: 1075\u20131081.","journal-title":"Journal of Infectious Diseases"},{"key":"BF02113429_CR12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/infdis\/165.1.105","volume":"165","author":"CAB Boucher","year":"1992","unstructured":"Boucher CAB, O'Sullivan E, Mulder JW, Ramautarsing C, Kellam P, Darby G, Lange JMA, Goudsmit J, Larder B: Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects. Journal of Infectious Diseases 1992, 165: 105\u2013110.","journal-title":"Journal of Infectious Diseases"},{"key":"BF02113429_CR13","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1073\/pnas.89.5.1934","volume":"89","author":"P Kellam","year":"1992","unstructured":"Kellam P, Boucher CAB, Larder BA: Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine. Proceedings of the National Academy of Sciences of the USA 1992, 89: 1934\u20131938.","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"BF02113429_CR14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM199307293290510","volume":"329","author":"JG Bartlett","year":"1993","unstructured":"Bartlett JG: Zidovudine now or later? New England Journal of Medicine 1993, 329: 351\u2013352.","journal-title":"New England Journal of Medicine"},{"key":"BF02113429_CR15","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/00002030-199211000-00003","volume":"6","author":"CAB Boucher","year":"1992","unstructured":"Boucher CAB, Lange JMA, Miedema FF, Weverling GJ, Koot M, Mulder JW, Goudsmit J, Kellam P, Larder B, Tersmette M: HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment. AIDS 1992, 6: 1259\u20131264.","journal-title":"AIDS"},{"key":"BF02113429_CR16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00002030-199102000-00002","volume":"5","author":"BA Larder","year":"1991","unstructured":"Larder BA, Kellam P, Kemp SD: Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes. AIDS 1991, 5: 137\u2013144.","journal-title":"AIDS"},{"key":"BF02113429_CR17","first-page":"527","volume-title":"Diagnostic molecular microbiology: principles and applications","author":"BA Larder","year":"1993","unstructured":"Larder BA, Boucher CAB: PCR detection of human immunodeficiency virus drug resistance mutations. In: Persing DH, Smith TF, Tenover FC, White TJ (ed): Diagnostic molecular microbiology: principles and applications. American Society for Microbiology, Washington, DC, 1993, p. 527\u2013533."},{"key":"BF02113429_CR18","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/00002030-198907000-00001","volume":"3","author":"R Rooke","year":"1989","unstructured":"Rooke R, Tremblay M, Soudeyns H, De Stephano L, Yao XJ, Fanning M, Montaner JSG, O'Shaughnessy M, Gelmon K, Tsoukas C, Gill J, Ruedy J, Wainberg MA, the Canadian Zidovudine Multi-Centre Study Group: Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapy. AIDS 1989, 3: 411\u2013415.","journal-title":"AIDS"},{"key":"BF02113429_CR19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1073\/pnas.90.1.25","volume":"90","author":"H Mohri","year":"1993","unstructured":"Mohri H, Singh MK, Ching WTW, Ho DD: Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients. Proceedings of the National Academy of Sciences of the USA 1993, 90: 25\u201329.","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"BF02113429_CR20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00002030-199302000-00006","volume":"7","author":"JSG Montaner","year":"1993","unstructured":"Montaner JSG, Singer J, Schechter MT, Raboud JM, Tsoukas C, O'Shaughnessy M, Ruedy J, Nagai K, Salomon H, Spira B, Wainberg MA: Clinical correlates of in vitro resistance to zidovudine. Results of the Multicentre Canadian AZT Trial. AIDS 1993, 7: 189\u2013196.","journal-title":"AIDS"},{"key":"BF02113429_CR21","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/infdis\/167.3.526","volume":"167","author":"MJ Kozal","year":"1993","unstructured":"Kozal MJ, Shafer RW, Winters MA, Katzenstein DA, Merigan TC: A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4+ lymphocyte numbers in long-term zidovudine recipients. Journal of Infectious Diseases 1993, 167: 526\u2013532.","journal-title":"Journal of Infectious Diseases"},{"key":"BF02113429_CR22","first-page":"891","volume":"6","author":"MH St. Clair","year":"1993","unstructured":"St. Clair MH, Hartigan PM, Andrews JC, Vavro CL, Simberkoff MS, Hamilton JD: Zidovudine resistance, syncytium-inducing phenotype, and HIV disease progression in a case-control study. Journal of Acquired Immune Deficiency Syndromes 1993, 6: 891\u2013897.","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"BF02113429_CR23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/infdis\/169.2.267","volume":"169","author":"F Luque","year":"1994","unstructured":"Luque F, Caruz A, Pineda JA, Torres Y, Lader B, Leal M: Provirus load changes in untreated and zidovudine treated human immunodeficiency virus type 1-infected patients. Journal of Infectious Diseases 1994, 169: 267\u2013273.","journal-title":"Journal of Infectious Diseases"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02113429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02113429\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02113429","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T00:55:51Z","timestamp":1557795351000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02113429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1995,6]]}},"alternative-id":["BF02113429"],"URL":"https:\/\/doi.org\/10.1007\/bf02113429","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,6]]}}}